Abstract
Bleomycin is an anti-tumour agent that is clinically used to treat several types of cancers. Bleomycin cleaves DNA at specific DNA sequences and recent genome-wide DNA sequencing specificity data indicated that the sequence 5′-RTGT*AY (where T* is the site of bleomycin cleavage, R is G/A and Y is T/C) is preferentially cleaved by bleomycin in human cells. Based on this DNA sequence, we constructed a plasmid clone to explore this bleomycin cleavage preference. By systematic variation of single nucleotides in the 5′-RTGT*AY sequence, we were able to investigate the effect of nucleotide changes on bleomycin cleavage efficiency. We observed that the preferred consensus DNA sequence for bleomycin cleavage in the plasmid clone was 5′-YYGT*AW (where W is A/T). The most highly cleaved sequence was 5′-TCGT*AT and, in fact, the seven most highly cleaved sequences conformed to the consensus sequence 5′-YYGT*AW. A comparison with genome-wide results was also performed and while the core sequence was similar in both environments, the surrounding nucleotides were different.
Similar content being viewed by others
Abbreviations
- CE-LIF:
-
Capillary electrophoresis with laser-induced fluorescence
- dNTP:
-
Deoxynucleotide triphosphates
- Exo-SAP:
-
Exonuclease I and shrimp alkaline phosphatase
- FAM-dUTP:
-
Aminoallyl-dUTP-6-FAM
References
Umezawa H, Maeda K, Takeuchi T, Okami Y (1966) J Antibiot 19:200–209
Kross J, Henner WD, Hecht SM, Haseltine WA (1982) Biochemistry 21:4310–4318
Suzuki H, Nagai K, Akutsu E, Yamaki H, Tanaka N, Umezawa H (1970) J Antibiot 23:473–480
Burger RM (1998) Chem Rev 98:1153–1170
Horwitz SB, Sausville EA, Peisach J (1979) In: Hecht SM (ed) Bleomycin: chemical, biochemical, and biological aspects. In: Proceedings of US–Japan Symposium, East-West Center, Honolulu, July 18–22, 1978. Springer New York, New York, NY, pp 170–183
Claussen CA, Long EC (1999) Chem Rev 99:2797–2816
Einhorn LH (2002) Proc Natl Acad Sci USA 99:4592–4595
Stoter G, Kaye SB, de Mulder PH, Levi J, Raghavan D (1994) J Clin Oncol 12:644–645
Neese F, Zaleski JM, Loeb Zaleski K, Solomon EI (2000) J Am Chem Soc 122:11703–11724
Burger RM, Projan SJ, Horwitz SB, Peisach J (1986) J Biol Chem 261:5955–5959
Chen J, Stubbe J (2005) Nat Rev Cancer 5:102–112
Stubbe J, Kozarich JW (1987) Chem Rev 87:1107–1136
Stubbe J, Kozarich JW, Wu W, Vanderwall DE (1996) Acc Chem Res 29:322–330
Hecht SM (2000) J Nat Product 63:158–168
D’Andrea AD, Haseltine WA (1978) Proc Natl Acad Sci USA 75:3608–3612
Povirk LF, Hogan M, Dattagupta N (1979) Biochemistry 18:96–101
Goodwin KD, Lewis MA, Long EC, Georgiadis MM (2008) Proc Natl Acad Sci USA 105:5052–5056
Wu W, Vanderwall DE, Turner CJ, Kozarich JW, Stubbe J (1996) J Am Chem Soc 118:1281–1294
Yu Z, Schmaltz RM, Bozeman TC, Paul R, Rishel MJ, Tsosie KS, Hecht SM (2013) J Am Chem Soc 135:2883–2886
Schroeder BR, Ghare MI, Bhattacharya C, Paul R, Yu Z, Zaleski PA, Bozeman TC, Rishel MJ, Hecht SM (2014) J Am Chem Soc 136:13641–13656
Steighner RJ, Povirk LF (1990) Proc Natl Acad Sci USA 87:8350–8354
Povirk LF, Wübker W, Köhnlein W, Hutchinson F (1977) Nucleic Acids Res 4:3573–3580
Cullinan EB, Gawron LS, Rustum YM, Beerman TA (1991) Biochemistry 30:3055–3061
Tounekti O, Kenani A, Foray N, Orlowski S, Mir LM (2001) Br J Cancer 84:1272–1279
Grimwade JE, Cason EB, Beerman TA (1987) Nucleic Acids Res 15:6315–6329
Hashimoto S, Wang B, Hecht SM (2001) J Am Chem Soc 123:7437–7438
Absalon MJ, Kozarich JW, Stubbe J (1995) Biochemistry 34:2065–2075
Absalon MJ, Wu W, Kozarich JW, Stubbe J (1995) Biochemistry 34:2076–2086
Sam JW, Takahashi S, Lippai I, Peisach J, Rousseau DL (1998) J Biol Chem 273:16090–16097
Sausville EA, Stein RW, Peisach J, Horwitz SB (1978) Biochemistry 17:2746–2754
Oberley LW, Buettner GR (1979) FEBS Lett 97:47–49
Caspary WJ, Lanzo DA, Niziak C (1982) Biochemistry 21:334–338
Dorr RT (1992) Semin Oncol 19:3–8
Rabow LE, Stubbe J, Kozarich JW (1990) J Am Chem Soc 112:3196–3203
Chen JK, Murray V (2016) J Biol Inorg Chem 21:395–406
Takeshita M, Grollman AP, Ohtsubo E, Ohtsubo H (1978) Proc Natl Acad Sci USA 75:5983–5987
Takeshita M, Kappen LS, Grollman AP, Eisenberg M, Goldberg IH (1981) Biochemistry 20:7599–7606
Mirabelli CK, Ting A, Huang CH, Mong S, Crooke ST (1982) Cancer Res 42:2779–2785
Murray V, Martin RF (1985) Nucleic Acids Res 13:1467–1481
Murray V, Tan L, Matthews J, Martin RF (1988) J Biol Chem 263:12854–12859
Nightingale KP, Fox KR (1993) Nucleic Acids Res 21:2549–2555
Murray V (2000) Prog Nucl Acid Res Mol Biol 63:367–415
Lewis MA, Long EC (2006) Bioorg Med Chem 14:3481–3490
Ma Q, Akiyama Y, Xu Z, Konishi K, Hecht SM (2009) J Am Chem Soc 131:2013–2022
Bozeman TC, Nanjunda R, Tang C, Liu Y, Segerman ZJ, Zaleski PA, Wilson WD, Hecht SM (2012) J Am Chem Soc 134:17842–17845
Segerman ZJ, Roy B, Hecht SM (2013) Biochemistry 52:5315–5327
Roy B, Hecht SM (2014) J Am Chem Soc 136:4382–4393
Roy B, Tang C, Alam MP, Hecht SM (2014) Biochemistry 53:6103–6112
Tang C, Paul A, Alam MP, Roy B, Wilson WD, Hecht SM (2014) J Am Chem Soc 136:13715–13726
Murray V, Martin RF (1985) J Biol Chem 260:10389–10391
Cairns MJ, Murray V (1996) Biochemistry 35:8753–8760
Kim A, Murray V (2000) Int J Biochem Cell Biol 32:695–702
Kim A, Murray V (2001) Int J Biochem Cell Biol 33:1183–1192
Temple MD, Freebody J, Murray V (2004) Biochim Biophys Acta 1678:126–134
Temple MD, Murray V (2005) Int J Biochem Cell Biol 37:665–678
Nguyen HTQ, Murray V (2012) J Biol Inorgan Chem 17:1209–1215
Murray V, Chen JK, Galea AM (2014) Cell Mol Life Sci 71:1505–1512
Murray V, Chen JK, Galea AM (2014) Mutat Res Fund Mol Mech Mutagen 769:93–99
Murray V, Chen JK, Tanaka MM (2016) Mol Biol Report 43:639–651
Paul M, Murray V (2012) Biomed Chromatogr 26:350–354
Nguyen TV, Murray V (2012) J Biol Inorg Chem 17:1–9
Murray V, Nguyen TV, Chen JK (2012) Chem Biol Drug Des 80:1–8
Nguyen TV, Chen JK, Murray V (2013) J Chromatogr B 913:113–122
White RJ, Phillips DR (1989) Biochemistry 28:4277–4283
Gordon LK, Haseltine WA (1980) J Biol Chem 255:12047–12050
Lobachevsky PN, Martin RF (2000) Radiat Res 153:271–278
Lobachevsky PN, Martin RF (1996) Acta Oncol 35:809–815
Chung LH, Murray V (2016) J Chromatogr B 1008:87–97
Inazuka M, Tahira T, Hayashi K (1996) Genome Res 6:551–557
Murray V, Martin RF (1994) Nucleic Acids Res 22:506–513
Nguyen TV, Murray V (2013) Biomed Chromatogr 27:390–395
Belikov S, Wieslander L (1995) Nucleic Acids Res 23:310
Chen JK, Yang D, Shen B, Neilan BA, Murray V (2016) Bioorg Med Chem 24:6094–6101
Calladine CR (1982) J Mol Biol 161:343–352
Povirk LF, Han YH, Steighner RJ (1989) Biochemistry 28:5808–5814
Kuo MT, Hsu TC (1978) Nature 271:83–84
Galea AM, Murray V (2010) Chem Biol Drug Des 75:578–589
Acknowledgements
Support of this work by the University of New South Wales, Science Faculty Research Grant Scheme is gratefully acknowledged. SDG was funded by an Australian Postgraduate Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gautam, S.D., Chen, J.K. & Murray, V. The DNA sequence specificity of bleomycin cleavage in a systematically altered DNA sequence. J Biol Inorg Chem 22, 881–892 (2017). https://doi.org/10.1007/s00775-017-1466-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-017-1466-z